Commissioning for value focus pack Clinical commissioning group: Focus area: Cardiovascular disease (CVD) pathway NHS NORTHERN, EASTERN AND WESTERN.

Slides:



Advertisements
Similar presentations
1 Commissioning for Value Insight packs Online Annexes NHS England Gateway ref:
Advertisements

Commissioning for Value Deep Dive Packs pilot Sue Baughan Public Health England.
Interpreting the Commissioning for Value Packs
Adding local value to Commissioning for Value
Using the commissioning for value packs and resources to improve population health.
What is a “Deep Dive” pack? 1 CCGs have received a bespoke Commissioning for Value insights pack. These packs, sometimes referred to a Level 1 packs, analyse.
Copyright 2011 Right Care Using “Deep Dive” Insights packs in Northern and Yorkshire CCGs Sue Baughan Associate Director, Knowledge and Intelligence Team.
Commissioning to reduce health inequalities: Supporting analysis
1 Key points – Heart Failure within Bradford 2011.
Commissioning for Value Tool Bryn Shorney Analytical Services.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
Improving the Quality of Physical Health Checks
Respiratory Benchmarking Packs Yorkshire and the Humber September 2010.
NHS Benchmarking Data Susan Hamilton Consultant in Public Health South Gloucestershire Council.
Using QOF and Service Specifications to meet HI Needs Rachel Foskett-Tharby.
Guide to CCG Data Profiles Version Version information and PDF production date The main part of the profile uses information on CCGs’ proposed practices.
Chronic kidney disease prevalence model October 2014 Gateway number
Tackling high blood pressure A case for CCG action Clinical Commissioning Group (CCG) slide deck – prepared 18/12/2015.
PUTTING PREVENTION FIRST Vascular Checks/ NHS Health Checks.
Quality and Outcomes Framework The national Quality and Outcomes Framework (QOF) was introduced as part of the new General Medical Services (GMS) contract.
Tools for displaying public health information Based on presentation created by Helen Cooke SWPHO Delivered by Isobel Perry, Senior Public Health Intelligence.
APHO’s Technical Work Paul Fryers Deputy Director – East Midlands PHO Technical Advisor – APHO.
GRASP-COPD Hannah Wall, Programme Delivery Manager
Diabetes Health Intelligence A Summary of Information: South Central SHA.
AF in the West Midlands: Prevalence, pathways and management Dr Indira Natarajan FRCP, Clinical Director for Stroke, West Midlands SCN & Senate Dr Orsolina.
Systematic QIPP Development Adoption of NHS Right Care
Consistency in diagnostic and treatment procedures Specifically angiography and angioplasty Dr Alison Round 14 October 2015.
CVD Prevention Optimal Value Pathway
National Stroke Audit Rehabilitation Services 2016
The GM AHSN AF Landscape Tool: A shared public data platform to promote quality improvements and identify opportunities to prevent AF-related stroke in.
QIPP, Turnaround & Right Care
Commissioning for Value Focus Pack
Tackling High Blood Pressure Through Community Pharmacy
JSNA briefing for Royal Borough Windsor and Maidenhead
Accessing health information in the UK
1000 Lives Plus: National Learning Event
Right Care Deep Dives NEW Devon CCG Blood Disorders.
Right Care Deep Dives NEW Devon CCG Infectious Diseases.
Respiratory Services Right Care Optimisation Workshop
Right Care Deep Dives NEW Devon CCG Poisoning.
Better Care Fund (previously known as Integration Transformation Fund)
Developing Accountable Care in Greater Nottingham
CVD Optimal Service Design Workshop Defining “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Adherence to Evidence Based Medicine Programme Evidence Summary Pack (Version 2) Hernia Local commissioners working with local people for a healthier.
Maternity and Neonatal, Skin, Vision and Hearing Deep Dive Workshop Understanding “what to change” using the NHS Right Care methodology Part of the NEW.
Adherence to Evidence Based Medicine Programme Evidence Summary Pack (Version 2) Knee Replacement Local commissioners working with local people for a.
Cancer Optimal Service Design Workshop Defining “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Improving Chronic Care Management
Fiona Caplan-Dean Pharmacy Services Development Manager UK
Local Tobacco Control Profiles The webinar will start at 1pm
Atrial Fibrillation Project, SSNAP July to September 2013 and QOF Indicators 2012/2013 Guildford and Waverley CCG.
Improving outcomes for CVD
CVD Secondary Prevention plans within Thames Valley
Neurological Services Deep Dive Workshop Understanding “what to change” using the NHS Right Care methodology Part of the NEW Devon Way.
Where are we with AF in the West Midlands?
Atrial Fibrillation Local data and data tools: February 2016
Harrow CCG CCG 360o stakeholder survey 2014 Summary report.
High Blood Pressure in General Practice: Variation and Opportunities South Cheshire CCG (v11) 5th March 2019.
Adherence to Evidence Based Medicine Programme Evidence Summary Pack (Version 2) Correction of Ptosis Local commissioners working with local people for.
CVD Secondary Prevention plans within Thames Valley
Healthy Hearts and Kick It
2017/18 National Diabetes Audit Cambridgeshire and Peterborough CCG local summary Public Health Intelligence, Cambridgeshire and Peterborough : April 2019.
NICE resources for STPs: MECC
DRAFT Granta Data pack January 2019.
Ely South PCN Data pack August 2019.
Ely North PCN Data pack August 2019.
Cambridge City PCN Data pack July 2019.
Octagon PCN Data pack August 2019.
Peterborough 1 PCN Data pack August 2019.
Tools to support development of interventions Soili Larkin & Mohammed Vaqar Public Health England West Midlands.
Presentation transcript:

Commissioning for value focus pack Clinical commissioning group: Focus area: Cardiovascular disease (CVD) pathway NHS NORTHERN, EASTERN AND WESTERN DEVON CCG December 2014 PHE publications gateway number 2014600 Version 3

Contents Contents Background and context About the packs Packs as part of transformation process: what and how to change Methodology Summary messages Analysis Analysis by pathway stage Local data: bringing it all together Annexes Annexe 1: Detailed indicator spine charts Annexe 2: CCG benchmarks Annexe 3: Statistical methodology Annexe 4: Data sources Annexe 5: Glossary Contents If this PowerPoint presentation is printed into hard copy, you must first check that the version number on your copy matches that of the commissioning for value PDF pack online.  Printed copies are uncontrolled copies. 2

Background About the packs This focus pack or deep dive looks at an agreed programme area (CVD) to understand variation and improve the value of commissioned services across the pathway Commissioning for value insight packs were produced for every Clinical Commissioning Group (CCG) in autumn 2013 by Public Health England (PHE), NHS England and NHS Right Care. These packs identified programme areas with potential opportunities for improving outcome, quality and efficiency at CCG level for the ten areas of programme expenditure with the highest spend. These are available at: www.england.nhs.uk/resources/resources-for-ccgs/comm-for-value/ This CVD focus pack is available in two formats: a downloadable PDF providing national benchmarked data for heart and stroke together with a summary of key messages: www.ncvin.org.uk/ an unbranded PowerPoint slide set that is available to CCGs on request to add additional local information and comment. Note, if the layout of this PowerPoint slide set or format of the charts are changed, the reference to the source data must be kept. Background 3

Background What and how to change How to change What to change Phase 1 This pack: Phase 2 Phase 3 The NHS Right Care model has three basic steps: The commissioning for value insight pack supports Where to look by indicating the areas of care where your population can gain most benefit from your reform energies. This focus pack or ‘deep dive’ supports What to change by helping you to define what the optimal value care looks like for your population. How to change helps you implement the changes to deliver the care. Support is available at: http://www.rightcare.nhs.uk/index.php/commissioning-for-value/ Background Where to look What to change How to change Business processes Clinical leadership and engagement Evidential data Deep dive service reviews Engagement and case for change Indicative data eg: Atlas of variation 4

Methodology used to produce this pack Analysed a wide range of indicators from across the pathway focussing on spend, quality and outcomes Identified ‘cluster groups’ of 10 CCGs with similar characteristics to the CCG (see slide 21) Analysed wide range of national data to identify indicators where the CCG is below a benchmark value in its cluster group for that indicator and thus has an opportunity to improve Identified indicators where the CCG is in the worst quintile within its cluster for that indicator (see slide 22 for more information on methodology) Methodology Identified key opportunities for value improvement and quantified potential impact Quantified opportunity for the CCG if indicators below the benchmark were moved to the benchmark Quantification does not mean that the ‘saving’ or improvement can actually be made but may answer the question ‘Is it going to be worth focussing on this area?’ Identified evidence based guidance, quality standards and performance metrics for people providing and commissioning health, public health and social care services for the prevention and management of CVD related conditions. For more information see slide 15 5

Summary: overarching messages Overarching messages for the CCG Public health focus on prevention; specifically smoking prevalence Significant benefit to patients if improvement to primary care management indicators were made High cost for: CVD elective admissions (female), CHD elective admissions (male), stroke emergency admissions (male), heart failure emergency admissions (female) High number of admissions for: CABG procedures Summary on a page Note 1, these opportunities represent indicators that are in the worst quintile of their cluster group. Other opportunities may also be available. These can be found in Annexe 1. Note 2, opportunities highlight areas for further investigation, as variation may reflect genuine differences due to local demography and service provision. Not all opportunities therefore may be achievable. See indicator guide for further information on how the indicators were calculated. 6

Summary: prevention and prevalence 4 out of 5 prevention indicators are worse than the benchmark. 1 indicator is in the worst quintile. Smoking prevalence is in the worst quintile. If the CCG were to achieve the benchmark then there would be 27,161 fewer adults who smoke. Prevalence 3 out of 3 of the observed to expected prevalence ratios are worse than the benchmark. The prevalence in 7 disease groups out of 7 are higher than the benchmark. Summary Note 3, These packs use two types of prevalence indicator. The observed prevalence diagnosed on practice registers and the ratio of observed to expected prevalence.  The expected prevalence is a modelled estimate of total prevalence (diagnosed and undiagnosed) which uses the characteristics of the population to estimate the expected total prevalence of disease in that population. A low ratio may indicate a higher level of undiagnosed cases of disease and therefore unmet need. 7

Summary Summary: primary care Primary care 25 out of 27 primary care indicators are worse than the benchmark. QOF indicators have been used but exceptions have been included in the denominator. The following 8 indicators are in the worst quintile, the potential benefits based on achieving the benchmark are shown in brackets: % hypertension patients <= 79 years BP < 140/90 (6,120 more people) % hypertension patients <75 years brief intervention (4,032 more people) % CHD patients last BP <150/90 (844 more people) % HF patients confirmed by echocardiogram (242 more people) % PAD patients BP < 150/90 (238 more people) % MI patients treated with ACE-I, Anti-platelet, BB, statin (148 more people) % HF patients due to LVSD treated with ACE-I or ARB and BB (119 more people) AF & CHADS2 score of 1, % anti-coag/platelet drug therapy (66 more people) Summary 8 Note 4, For full QOF names, see indicator guide.

Summary: secondary care 50 out of 54 secondary care indicators are worse than the benchmark. 6 indicators are in the worst quintile. The four in terms of money and the two in terms of admissions/procedures are listed below, the potential savings based on achieving the benchmark are shown in brackets: -CVD: average cost per female elective admission (£618K) -CHD: average cost per male elective admission (£481K) -Heart failure: average cost per female emergency admission (£143K) -Stroke: average cost per male emergency admission (£49K) -CABG procedures: male (DSR) (172 fewer procedures) -CABG procedures: female (DSR) (46 fewer procedures) Summary Note 5, CCG length of stay averages may be influenced by extreme values. Further analysis may be needed to determine achievability of any related opportunity. Note 6, CABG indicators may be based on small numbers. Caution is advised on the use of these indicators. 9

Summary Summary: social care Social care 1 out of 1 social care indicators are worse than the benchmark. There are no indicators in the worst quintile. Summary 10

Where does the CCG compare poorly against its cluster group? Analysis by pathway stage (page 1 of 2) Analysis Table1 11 *below a benchmark value equal to the average of the top 5 ranked CCG values in their cluster group

Where does the CCG compare poorly against its cluster group? Analysis by pathway stage (page 2 of 2) Analysis Table2 12 *below a benchmark value equal to the average of the top 5 ranked CCG values in their cluster group

Where to focus: understanding practice variation The NCVIN can provide practice level data for CCGs on request: ncvin@phe.gov.uk. This will allow CCGs to better understand practice variation. Practices are clustered with other practices across the country with similar populations. The practice is then compared with the other practices within that cluster for all the indicators where the data is available at practice level. This information is not presented routinely in these packs as CCGs will want to use it sensitively as the basis of a discussion with practices to better understand the reasons for variation and the reduction of variation not explained by clinical need. Analysis 13

Where to focus: adding local data An unbranded power point slide set is available to CCGs on request to add additional local information and comment. These can be requested through the NCVIN: ncvin@phe.gov.uk CCGs may want to consider adding local intelligence to triangulate with the intelligence in this pack. This may include: Up to date intelligence from providers Contract monitoring data Local prescribing data Joint Strategic Needs Assessment (JSNA) Preventative activity commissioned by local authorities Data on inequalities Local data can be particularly useful when: Testing the size of the opportunities identified from the national data in this pack Linking to identified needs of the population Testing whether plans introduced since this data was collected have worked Testing whether commissioned services are accessed by those in greatest need Analysis 14

Bring it all together: what works, what could work, who should we speak to NICE Guidance, Quality Standards etc Prevention of cardiovascular disease Hypertension Atrial fibrillation Stroke Chronic heart failure Lipid modification Myocardial infarction with ST segment elevation Lower limb peripheral arterial disease Smoking prevention and cessation Obesity Physical activity Contact the NICE field team for support and advice on implementing NICE guidance The quality and productivity collection provides quality assured examples of improvements across NHS and social care and include cardiovascular and stroke. Look at NICE shared learning examples from organisations that have put guidance into practice. Examples include peripheral arterial disease, hypertension and obesity. Analysis 15

Annexes Annexe 1: spine charts 16 Key: Prevention Prevalence England worst England best Key: Worst quintile in cluster Annexes Prevention Worse outcome \ High prevalence Better outcome \ Low prevalence Opportunity Prevalence 16 See indicator guide for methodology used to calculate the indicators For data sources used, see slide 23

Annexes Annexe 1: spine charts 17 Key: Primary care England worst England best Key: Worst quintile in cluster Annexes Primary care Worse outcome Better outcome Opportunity 17 See indicator guide for methodology used to calculate the indicators For data sources used, see slide 23

Annexes Annexe 1: spine charts 18 Key: Secondary care England worst England best Key: Worst quintile in cluster Annexes Secondary care Worse outcome Better outcome Opportunity 18 See indicator guide for methodology used to calculate the indicators For data sources used, see slide 23

Annexes Annexe 1: spine charts 19 Key: Secondary care continued England worst England best Key: Worst quintile in cluster Annexes Secondary care continued Worse outcome Better outcome Opportunity 19 See indicator guide for methodology used to calculate the indicators For data sources used, see slide 23

Annexes Annexe 1: spine charts 20 Key: Secondary care continued England worst England best Key: Worst quintile in cluster Annexes Secondary care continued Worse outcome Better outcome Opportunity Social care 20 See indicator guide for methodology used to calculate the indicators For data sources used, see slide 23

Annexes Annexe 2: similar CCGs The 10 most similar CCGs to NHS NORTHERN, EASTERN AND WESTERN DEVON CCG are: NHS DORSET CCG NHS CAMBRIDGESHIRE AND PETERBOROUGH CCG NHS OXFORDSHIRE CCG NHS KERNOW CCG NHS GLOUCESTERSHIRE CCG NHS SOMERSET CCG NHS CUMBRIA CCG NHS NENE CCG NHS WEST HAMPSHIRE CCG NHS SOUTHERN DERBYSHIRE CCG For information on the methodology used to calculate the 10 most similar CCGS please go to: http://www.england.nhs.uk/resources/resources-for-ccgs/comm-for-value/ Annexes 21

Annexe 3: Statistical methodology The methodology used in this pack consisted of the following steps: For each indicator: Data were ranked within the cluster A benchmark value was calculated as the average of the top 5 ranked CCG values The opportunity that could be gained if the CCG were to improve to the benchmark value was calculated The worst quintile was identified as the worst 2 ranked values If the indicator lay in the worst quintile then it was highlighted as a potential area for investigation For more information, see indicator guide. This is a non-parametric statistical approach which was designed to be easy to understand and interpret. While the comparison does not necessarily prove statistical significance it does provide a robust indication of the most promising areas for further investigation. Annexes 22

Annexes Annexe 4: Data sources Data sources used: Quality and Outcomes Framework (QOF), 2013/14, Copyright © 2014, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved Number of Patients registered at a GP practice – April 2013, Copyright © 2014, Re-used with the permission of the Health and Social Care Information Centre. All rights reserved Modelled estimates of prevalence, December 2011, East of England Public Health Observatory Mid-2012 Population Estimates for Clinical Commissioning Groups, Office for National Statistics (ONS), © Crown Copyright 2014 Hospital Episode Statistics (HES), 2012/13, Copyright © 2014, Re‐used with the permission of The Health and Social Care Information Centre. All rights reserved. Model-based estimates (based on Health Survey for England), 2006-08 and 2007/08 Integrated Household Survey, 2012 Active people survey, Sport England, 2012 Annexes 23

Annexes Annexe 5: Glossary AF Atrial fibrillation BP Blood pressure CABG Coronary artery bypass graft CCG Clinical Commissioning Group CHADS2 A method of calculating the risk of stroke in patients with atrial fibrillation (AF) CHD Coronary heart disease CVD Cardiovascular disease DSR Directly standardised rate LOS Length of stay LVSD Left ventricular systolic dysfunction PAD Peripheral Arterial Disease QOF Quality Outcomes Framework Annexes 24